Airfree
Developed an innovative solution with enormous health benefits for het child by eliminating the allergens responsible for respiratory allergies.
Launch date
Employees
Market cap
-
Enterprise valuation
€9—14m (Dealroom.co estimates May 2019.)
Lisbon Lisbon (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 3.2m | 3.7m | 3.7m | 3.7m | 3.7m |
| % growth | - | 16 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €890k | Seed | |
$2.6m | Series A | ||
| Total Funding | €3.3m | ||
Related Content
Recent News about Airfree
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.